Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PRAMIPEXOLE | 1.0MG | TABLET | Resolved | 2018-11-30 | 2019-01-03 | 68239 |
| APO-PRAMIPEXOLE | 1.5MG | TABLET | Resolved | 2019-01-03 | 2019-03-16 | 71142 |
| APO-PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2019-10-16 | 2020-01-13 | 96653 |
| APO-PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2020-06-04 | 2020-08-17 | 116561 |
| APO-PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2020-11-19 | 2021-01-26 | 128615 |
| APO-PRAMIPEXOLE | 1.0MG | TABLET | Resolved | 2021-01-18 | 2021-01-19 | 131886 |
| APO-PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2021-06-25 | 2021-09-14 | 141540 |
| APO-PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2022-02-04 | 2022-04-15 | 154187 |
| APO-PRAMIPEXOLE | 1.0MG | TABLET | Resolved | 2022-11-20 | 2023-04-14 | 175324 |
| APO-PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2023-02-02 | 2023-04-14 | 183483 |
| APO-PRAMIPEXOLE | 0.5MG | TABLET | Resolved | 2023-02-23 | 2023-04-14 | 185465 |
| APO-PRAMIPEXOLE | 1.5MG | TABLET | Resolved | 2023-11-17 | 2023-12-08 | 210659 |
| APO-PRAMIPEXOLE | 1.5MG | TABLET | Resolved | 2024-03-22 | 2024-04-26 | 223055 |
| APO-PRAMIPEXOLE | 0.25MG | TABLET | Resolved | 2024-04-12 | 2024-04-26 | 224993 |
| APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2017-03-11 | 2017-08-25 | 444 |
| APO-PRAVASTATIN | 20MG | TABLET | Resolved | 2017-03-11 | 2017-08-31 | 595 |
| APO-PRAVASTATIN | 10MG | TABLET | Resolved | 2017-03-20 | 2017-04-24 | 3533 |
| APO-PRAVASTATIN | 10MG | TABLET | Resolved | 2017-05-24 | 2017-12-20 | 11038 |
| APO-PRAVASTATIN | 10MG | TABLET | Resolved | 2017-06-08 | 2017-09-22 | 12361 |
| APO-PRAVASTATIN | 40MG | TABLET | Resolved | 2017-09-27 | 2017-11-23 | 23619 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |